CEACAM1-Mediated Inhibition of Virus Production.

PubWeight™: 0.77‹?›

🔗 View Article (PMID 27264178)

Published in Cell Rep on June 02, 2016

Authors

Alon Vitenshtein1, Yiska Weisblum2, Sebastian Hauka3, Anne Halenius4, Esther Oiknine-Djian2, Pinchas Tsukerman1, Yoav Bauman1, Yotam Bar-On1, Noam Stern-Ginossar1, Jonatan Enk1, Rona Ortenberg5, Julie Tai1, Gal Markel5, Richard S Blumberg6, Hartmut Hengel4, Stipan Jonjic7, Dana G Wolf2, Heiko Adler8, Robert Kammerer9, Ofer Mandelboim10

Author Affiliations

1: The Lautenberg Center for General and Tumor Immunology, The BioMedical Research Institute Israel Canada of the Faculty of Medicine (IMRIC), The Hebrew University Hadassah Medical School, 91120 Jerusalem, Israel.
2: Department of Clinical Microbiology and Infectious Diseases, Hadassah University Hospital, 91120 Jerusalem, Israel.
3: Institute for Virology, Heinrich-Heine-University, 40225 Düsseldorf, Germany.
4: Institute of Virology, Medical Center, University of Freiburg, 79104 Freiburg, Germany.
5: Ella Institute of Melanoma, Cancer Research Center Sheba Medical Center, 5262000 Tel Hashomer, Israel; Department of Clinical Microbiology and Immunology, Sackler Faculty of Medicine, Tel Aviv University, 6997801 Tel Aviv, Israel.
6: Gastroenterology Division, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.
7: Department of Histology and Embryology and Center for Proteomics, Faculty of Medicine, University of Rijeka, HR-51000 Rijeka, Croatia.
8: Helmholtz Zentrum München, German Research Center for Environmental Health (GmbH), Research Unit Gene Vectors, 81377 Munich, Germany.
9: Institute of Immunology, Friedrich Loeffler Institute, Federal Research Institute for Animal Health, 17493 Greifswald-Insel Riems, Germany.
10: The Lautenberg Center for General and Tumor Immunology, The BioMedical Research Institute Israel Canada of the Faculty of Medicine (IMRIC), The Hebrew University Hadassah Medical School, 91120 Jerusalem, Israel. Electronic address: oferm@ekmd.huji.ac.il.

Articles cited by this

Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses. Nature (2006) 22.65

Virus interference. I. The interferon. Proc R Soc Lond B Biol Sci (1957) 13.46

MatInspector and beyond: promoter analysis based on transcription factor binding sites. Bioinformatics (2005) 11.75

IFI16 is an innate immune sensor for intracellular DNA. Nat Immunol (2010) 8.97

Type I interferons in host defense. Immunity (2006) 7.32

Protocol for the fast chromatin immunoprecipitation (ChIP) method. Nat Protoc (2006) 6.24

Type I interferon [corrected] gene induction by the interferon regulatory factor family of transcription factors. Immunity (2006) 5.36

Inhibition of retinoic acid-inducible gene I-mediated induction of beta interferon by the NS1 protein of influenza A virus. J Virol (2006) 4.88

A class I antigen, HLA-G, expressed in human trophoblasts. Science (1990) 4.36

Triggering the innate antiviral response through IRF-3 activation. J Biol Chem (2007) 3.43

CEACAM1: contact-dependent control of immunity. Nat Rev Immunol (2006) 2.81

Nucleic acid sensing at the interface between innate and adaptive immunity in vaccination. Nat Rev Immunol (2012) 2.48

The TORrid affairs of viruses: effects of mammalian DNA viruses on the PI3K-Akt-mTOR signalling pathway. Nat Rev Microbiol (2008) 2.08

Viral subversion of the host protein synthesis machinery. Nat Rev Microbiol (2011) 2.07

Human cytomegalovirus protein UL38 inhibits host cell stress responses by antagonizing the tuberous sclerosis protein complex. Cell Host Microbe (2008) 1.85

The carboxyl-terminal region of biliary glycoprotein controls its tyrosine phosphorylation and association with protein-tyrosine phosphatases SHP-1 and SHP-2 in epithelial cells. J Biol Chem (1999) 1.46

Human cytomegalovirus tegument protein pUL83 inhibits IFI16-mediated DNA sensing for immune evasion. Cell Host Microbe (2013) 1.44

Differential susceptibility of different cell lines to swine-origin influenza A H1N1, seasonal human influenza A H1N1, and avian influenza A H5N1 viruses. J Clin Virol (2009) 1.33

Influenza virus mRNA translation revisited: is the eIF4E cap-binding factor required for viral mRNA translation? J Virol (2007) 1.15

The changing role of mTOR kinase in the maintenance of protein synthesis during human cytomegalovirus infection. J Virol (2011) 1.12

Pathogenic Neisseria trigger expression of their carcinoembryonic antigen-related cellular adhesion molecule 1 (CEACAM1; previously CD66a) receptor on primary endothelial cells by activating the immediate early response transcription factor, nuclear factor-kappaB. J Biol Chem (2001) 1.07

Shp2 negatively regulates growth in cardiomyocytes by controlling focal adhesion kinase/Src and mTOR pathways. Circ Res (2008) 1.07

Homophilic adhesion and CEACAM1-S regulate dimerization of CEACAM1-L and recruitment of SHP-2 and c-Src. J Cell Biol (2009) 1.06

The PTPN11 loss-of-function mutation Q510E-Shp2 causes hypertrophic cardiomyopathy by dysregulating mTOR signaling. Am J Physiol Heart Circ Physiol (2011) 1.02

Modeling of human cytomegalovirus maternal-fetal transmission in a novel decidual organ culture. J Virol (2011) 0.96

CEACAM1: a key regulator of vascular permeability. J Cell Sci (2010) 0.94

Role of interferon regulatory factor-1 in the induction of biliary glycoprotein (cell CAM-1) by interferon-gamma. J Biol Chem (1996) 0.86

Human cytomegalovirus disrupts the major histocompatibility complex class I peptide-loading complex and inhibits tapasin gene transcription. J Virol (2011) 0.86

Biological function of the soluble CEACAM1 protein and implications in TAP2-deficient patients. Eur J Immunol (2004) 0.86

SHP-2 regulates cell growth by controlling the mTOR/S6 kinase 1 pathway. J Biol Chem (2007) 0.83